focus -WSS

focus

author：knowledge 2025-09-28 23:10:50 - browse：9

How does a drug industry lobbying group move forward after years of upheaval, including having four CEOs in four years?

This week on “The Readout LOUD,” STAT’s Chief Washington Correspondent Rachel Cohrs Zhang joins us to discuss the layoffs at trade group BIO and how things may be changing at the trade group. We also invite STAT reporter Eric Boodman on to talk about his new investigative series of stories exploring how Black women with sickle cell disease were coerced into getting sterilized.

To read the first article in the Coercive Care investigative series and find future installments, go here; For more on the layoffs at BIO, go here; To keep tabs on health policy and BIO’s reorganization, sign up for the D.C. Diagnosis newsletter here; And you can sign up for Adam’s new newsletter, Biotech Scorecard, here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Letters to First Opinion on caregivers, digital health, and more

WSS

IVG is promising — but it won’t replace IVF quite yet

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

NIH documents show early flaws of $1.6 billion long Covid program

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

RSV injection headlines need to be accurate for good uptake

focus

focus

explore

Guidelines to prevent youth baseball injuries need more muscle

6 solutions to address cancer drug shortages and others

Medicare proposal to cover medical devices draws a mixed reaction

BMI, flaws aside, is found to be useful estimate of body fat in youth

George Santos makes 1st court appearance after pleading not guilty to 13 counts

WHO recommends second malaria vaccine

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Health insurers' Q3 question: how much care are people getting?

What does generative AI mean for health care? We asked experts

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

hotspot

European officials brace for rough respiratory virus season

What we owe ALS patients — and why one company fell short

Ultragenyx gene therapy for rare liver ailment succeeds in late

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

The Pandemic Treaty must support building strong health systems

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

entertainment

hotspot

explore

focus